KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

KORU Medical Systems Inc.

REPRO-MED Systems ( ($KRMD) ) has shared an announcement. On March 30, 2026, KORU Medical Systems, Inc. amended its existing $10 million credit fac...

REPRO-MED Systems Amends Credit Facility to Enhance Flexibility

In a report released today, from B. Riley Securities reiterated a Buy rating on REPRO-MED Systems, with a price target of $8.00. In addition to B. ...

B. Riley Securities Remains a Buy on REPRO-MED Systems (KRMD)

Piper Sandler analyst Jason Bednar reiterated a Hold rating on REPRO-MED Systems today and set a price target of $5.00. Bednar covers the Healthcar...

REPRO-MED Systems (KRMD) Gets a Hold from Piper Sandler

In a report released today, Caitlin Roberts from Canaccord Genuity reiterated a Buy rating on REPRO-MED Systems, with a price target of $6.00. Robe...

Canaccord Genuity Keeps Their Buy Rating on REPRO-MED Systems (KRMD)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on MBX Biosciences, Inc. (MBX – Research Report) and RE...

Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD)

Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems today and set a price target of $8.00. Takkinen covers the Healthca...

Current Quarter	$-0.01	Next Quarter	$-0.01
Current Year	$-0.03	Next Year	$0.06
QoQ Growth	+0.0%	YoY Growth	+300.0%
3Y EPS CAGR	-9.1%	Target Price	$6.80
Consensus	Buy	Upside	+60.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KRMD	$4.24	0.00%	76.68K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KRMD	$4.24	0%	76.68K
3
4
5
6

KRMD

KRMD

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get KORU Medical Systems Inc. Data in Excel

Get KORU Medical Systems Inc. Data in Excel